Moderna
MRNA
#1187
Rank
NZ$27.02 B
Marketcap
$70.23
Share price
7.48%
Change (1 day)
-45.90%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -NZ$7.17 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$4.98 Billion. In 2023 the company made an earning of -NZ$6.67 Billion a decrease over its 2022 earnings that were of NZ$16.40 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$7.17 Billion7.38%
2023 -NZ$6.67 Billion-140.65%
2022 NZ$16.40 B-27.81%
2021 NZ$22.72 B-1911.15%
2020 -NZ$1.26 Billion44.7%
2019 -NZ$0.87 Billion28.63%
2018 -NZ$0.68 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$59.79 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$28.16 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$71.35 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.32 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.75 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$0.9 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$31.42 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.21 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA